Origen de la red de primer grado Cynthia Poa.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Verimmune, Inc.
Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.
6
| Holding Company | Biotechnology | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Cynthia Poa a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Thomas Jefferson University | College/University | Corporate Officer/Principal | |
NOVELSTEM INTERNATIONAL CORP. | Biotechnology | Director/Board Member | |
MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MAXCYTE, INC. | Biotechnology | Corporate Officer/Principal | |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
Janssen R&D Ireland Ltd. | President | ||
ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member | |
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Pharmaceuticals: Major | Director/Board Member | |
American Graduate School of Management | College/University | Masters Business Admin | |
Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Other Consumer Services | Chairman | |
American Bank (Allentown, Pennsylvania)
American Bank (Allentown, Pennsylvania) Regional BanksFinance Part of American Bank, Inc., American Bank (Allentown, PA) is a financial institution that reflects the goals and aspirations of its customers. The company offers a range of products and services and provides personalized customer care. Mark W. Jaindl has been the CEO of the company since 1997. | Regional Banks | Director/Board Member | |
ADMA Plasma Biologics, Inc.
ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ. | Biotechnology | Director/Board Member | |
CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer | |
The Sophie Davis School of Biomedical Education | College/University | Undergraduate Degree | |
Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chief Executive Officer | |
Tibotec Pharmaceuticals | Chief Executive Officer | ||
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
SERES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chairman | |
Janssen Therapeutics, Inc. | President | ||
Labconnect Holdings, Inc.
Labconnect Holdings, Inc. Medical/Nursing ServicesHealth Services Labconnect Holdings, Inc. engages in providing laboratory services which include routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical. The company is headquartered in Seattle, WA. | Medical/Nursing Services | Chairman | |
Pomerantz Life Sciences Consulting Group LLC | President | ||
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
InFUSE Holdings, Inc.
InFUSE Holdings, Inc. Medical/Nursing ServicesHealth Services InFUSE Holdings, Inc. owns and operates ambulatory infusion centers. The company was founded by Timothy P. Johnson, Eric I. Richman, David M. Rothenberg, Gregory Gottschlich and is headquartered in Bethesda, MD. | Medical/Nursing Services | Founder | |
GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
VIRACTA THERAPEUTICS, INC. | Chairman | ||
INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
LabConnect, Inc.
LabConnect, Inc. Medical/Nursing ServicesHealth Services Labconnect LLC provides global central laboratory services. It offers routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services. The company serves biopharmaceutical, medical device and contract research organizations. Labconnect was founded by Jeff Mayhew in 2002 and is headquartered in Seattle, WA. | Medical/Nursing Services | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 44 |
Israel | 4 |
Irlanda | 3 |
Sectorial
Health Technology | 29 |
Consumer Services | 8 |
Health Services | 5 |
Commercial Services | 3 |
Finance | 3 |
Operativa
Director/Board Member | 32 |
Chairman | 13 |
Corporate Officer/Principal | 12 |
President | 9 |
Chief Executive Officer | 8 |
Las relaciones más conectadas
Insiders | |
---|---|
Roger Pomerantz | 30 |
Eric Richman | 21 |
Solomon Langermann | 10 |
John Troyer | 5 |
Joshua Weiyuan Wang | 2 |
Kevin Koh | 1 |
- Bolsa de valores
- Insiders
- Cynthia Poa
- Conexiones Empresas